MedPath

An exploratory study of NS-580 in patients with endometriosis (early phase II)

Phase 2
Completed
Conditions
endometriosis
Registration Number
JPRN-jRCT2080223592
Lead Sponsor
ippon Shinyaku Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
Female
Target Recruitment
150
Inclusion Criteria

Patients who have been clinically diagnosed with endometriosis

Exclusion Criteria

Patients for whom surgical treatment for an organic disease is judged by the principal (sub-) investigator to be a priority
Patients with ovarian endometriomas that are found to be containing solid components
Patients who may be taking analgesics regularly during the study period

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
efficacy<br>exploratory<br>The change in pain VAS score
Secondary Outcome Measures
NameTimeMethod
efficacy<br>exploratory<br>The change in EHP-30 score
© Copyright 2025. All Rights Reserved by MedPath